A Brief Report of the Status of Central Nervous System Metastasis Enrollment Criteria for Advanced Non–Small Cell Lung Cancer Clinical Trials: A Review of the ClinicalTrials.gov Trial Registry
- 1 March 2016
- journal article
- review article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 11 (3) , 407-413
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Safety and activity of pembrolizumab in melanoma patients with untreated brain metastases.Journal of Clinical Oncology, 2015
- Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.Journal of Clinical Oncology, 2015
- Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO groupThe Lancet Oncology, 2013
- Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO groupThe Lancet Oncology, 2013
- Review of Ongoing Clinical Trials in Non–Small-Cell Lung Cancer: A Status Report for 2012 from the ClinicalTrials.gov Web SiteJournal of Thoracic Oncology, 2013
- Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung CancerNew England Journal of Medicine, 2013
- Enrollment of Patients With Lung and Colorectal Cancers Onto Clinical TrialsJournal of Oncology Practice, 2013
- Non-small cell lung cancer and silent brain metastasisLung Cancer, 2009
- Treatment of brain metastases from lung cancer: chemotherapyLung Cancer, 2004
- On the Interpretation of χ 2 from Contingency Tables, and the Calculation of PJournal of the Royal Statistical Society, 1922